RLMD Latest Press Releases

-- June 11, 2026 --

Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program Globe Newswire 7:00 AM

-- May 28, 2026 --

Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference Globe Newswire 7:00 AM

-- May 12, 2026 --

Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- May 6, 2026 --

Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026 Globe Newswire 7:00 AM

-- May 5, 2026 --

Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026 Globe Newswire 7:00 AM

-- March 19, 2026 --

Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update Globe Newswire 4:01 PM

-- March 12, 2026 --

Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026 Globe Newswire 7:00 AM

-- March 9, 2026 --

Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference Globe Newswire 4:30 PM

Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing Globe Newswire 7:05 AM

Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software